Skip to main content
SpringerLink
Log in

Second treatment with fludarabine in a Waldenström's macroglobulinemia patient

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Waldenström JG . Incipient myelomatosis or ‘essential’ hyperglobulinemia with fibrinogenopenia–a new syndrome? Acta Med Scand 1944 117: 216–222

    Article  Google Scholar 

  2. Brouet JC, Clauvel JP, Seligmann M . Evolution et pronostic de la maladie de Waldenström. Etude de 150 observations Act Hématol (Paris) 1975 9: 38–47

    Google Scholar 

  3. Facon T, Bouillard M, Duhamel A, Morel P, Simon M, Jouet JP, Bauters F, Fenaux P . Prognostic factors in Waldenström's macroglobulinemia: a report of 167 cases J Clin Oncol 1993 11: 1553–1558

    Article  CAS  PubMed  Google Scholar 

  4. Leblond V, Ben-Othman T, Deconinck E, Taskin AL, Harousseau JL, Delgado MA, Delmer A, Maloisel F, Mariette X, Morel P, Clauvel JP, Duboisset P, Entezam S, Hermine O, Merlet M, Yakoub-Agha I, Guibon O, Caspard H, Fort N . Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases J Clin Oncol 1998 16: 2060–2064

    Article  CAS  PubMed  Google Scholar 

  5. Tallman MS, Hakimian D . Purines nucleoside analogs: emerging roles in indolent lymphoproliferative disorders Blood 1995 86: 2463–2474

    CAS  PubMed  Google Scholar 

  6. Wright SJ, Robertson LE, O'Brien S, Plunkett W, Keating MJ . The role of fludarabine in hematological malignancies Blood Rev 1994 8: 125–134

    Article  CAS  PubMed  Google Scholar 

  7. Dimopoulos MA, O'Brien S, Kantarjian H, Pierce S, Delavalle K, Barlogie B, Alexanian R, Keating MJ . Fludarabine therapy in Waldenstrom's macroglobulinemia Am J Med 1993 95: 49–52

    Article  CAS  PubMed  Google Scholar 

  8. Leblond V, Cazin B, Fermand JP, Harousseau JL, Maloisel F, Remenieras JJ, Guibon O . Results of a multicentric randomized study comparing the efficacy of cyclophosphamide, doxorubicin, and prednisone (CAP) to that of fludarabine (FAMP) in patients with Waldenström's macroglobulinemia in first relapse or primary refractory disease. VII International Conference on Malignant Lymphoma, Lugano, 2–5 June 1999

  9. O'Brien S, Kantarjian H, Keating MJ . Purine analogs in chronic lymhocytic leukemia and Waldenström's macroglobulinemia Ann Oncol 1996 7: (Suppl. 6) S27–S33

    Article  PubMed  Google Scholar 

  10. Saven A, Burian C, Koziol JA, Piro LD . Long-term follow-up of patients with hairy cell leukemia after cladribine treatment Blood 1998 92: 1918–1926

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Onco-Haematology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France

    F Maloisel, F CAmpos, C Giron & P Dufour

Authors
  1. F Maloisel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F CAmpos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C Giron
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Dufour
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maloisel, F., CAmpos, F., Giron, C. et al. Second treatment with fludarabine in a Waldenström's macroglobulinemia patient. Leukemia 14, 220 (2000). https://doi.org/10.1038/sj.leu.2401625

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401625

  • Springer Nature Limited

Search

Navigation